Company / Shareholders' Equity
Glaukos Corp. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$656.2M
FY2025
5-year range
$461.8M / $766.9M
FY2021-FY2025
Trend
-14.4%
vs FY2024
Sector context
#102 of 166
Health Care
What the data says
At $656M, Glaukos Corp.'s shareholders' equity ranks #102 of 166 in the Health Care sector. Shareholders' Equity has fluctuated over the past 10 years, ranging from $117M in FY2016 to $767M in FY2024.
Based on SEC 10-K filings.
$656M in FY2025 with a 5-year CAGR of -0.3%.
Improved from $462M to $656M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +7.4%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
#102 of 166 in Health CareTop 61% of 166This company $656.2M Sector average $5.3B
▼
-87.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.3%, indicating a declining trend.
- In FY2025, shareholders' equity decreased 14.4% year-over-year.
- Ranks #102 out of 166 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $656.2M | -14.4% |
| FY2024 | $766.9M | +66.1% |
| FY2023 | $461.8M | -12.9% |
| FY2022 | $530.0M | -9.7% |
| FY2021 | $587.2M | -12.0% |
| FY2020 | $667.4M | -0.9% |
| FY2019 | $673.3M | +287.2% |
| FY2018 | $173.9M | +25.8% |
| FY2017 | $138.2M | +17.8% |
| FY2016 | $117.3M | +23.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026